Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 12 pembrolizumab 8 Nivolumab 8 Biopsy 7 Radiotherapy 6 Temozolomide 4 Specimen Handling 4 Radiosurgery 4 Cyclophosphamide 4 fludarabine 3 X-Rays 3 Surgical Procedures, Operative 3 Paclitaxel 3 Leukapheresis 3 Ipilimumab 3 Fluorodeoxyglucose F18 3 Aspirin 3 perflutren 2 alovudine 2 Tirzepatide 2 Rituximab 2 Positron-Emission Tomography 2 Phantoms, Imaging 2 Omeprazole 2 Niacinamide 2 Neoadjuvant Therapy 2 Losartan 2 Letrozole 2 Ketoconazole 2 Immunotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Immunoconjugates × 90 days × Clear all

NCT07052760 2026-04-29

Imaging of Solid Tumors Using DLL3 SPECT

University of California, San Francisco

Phase EARLY_PHASE1 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡